NCT07057076Completed
Microbiome and Colorectal Cancer Recurrence
The Role of Microbiome in Recurrence After Colorectal Cancer Surgery With Postoperative Organ/Space Surgical Site Infection
Source: ClinicalTrials.gov · Last updated 9 Jul 2025
Brief summary (registry, in English)
Anastomotic leak is associated with higher rates of tumor recurrence after colorectal cancer surgery. However, the mechanisms responsible remain unknown. The aim of this study is to identify associations between the peritoneal microbiome and recurrence in colorectal cancer patients with postoperative anastomotic leak. This is a single-center retrospective study of patients undergoing colorectal cancer surgery complicated with anastomotic leak between 2004 and 2012. Samples of peritoneal fluid were collected either through percutaneous drainage or reoperation, and microbiome was analyzed using whole genome shotgun. Oncological outcomes are registered. Associations between peritoneal microbiome and tumor recurrence are investigated.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 51 (actual)
- First submitted
- 29 Jun 2025
- Start date
- Jan 2004
- Primary completion date
- Jun 2024
- Lead sponsor
- Hospital del Mar
- Diseases
- Colorectal cancer
- NCT number
- NCT07057076
What you commit to
- Study type: Observational
- Participants enrolled: 51
- From Jan 2004 to the primary completion date, Jun 2024
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Non-curative resection.
- Urgent surgery.
Who the study is looking for
- Colorectal cancer patients operated on for cure and complicated with anastomotic leak.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.